Tobacco Addiction Clinical Trial
— SmokerfaceOfficial title:
Smokerface: A Photoaging Mobile App Promoting Poster Campaign for Preventing Smoking in Secondary Schools: Randomized Controlled Trial
The purpose of this study is to determine whether photoaging mobile app promoting poster campaigns are effective to reduce smoking prevalence among adolescents in Germany. This is measured via questionnaire.
Status | Active, not recruiting |
Enrollment | 12000 |
Est. completion date | July 2018 |
Est. primary completion date | July 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 9 Years to 17 Years |
Eligibility |
Inclusion Criteria: - Students from Germany aged 9 to 14 years at baseline attending grades six and seven of regular German secondary schools (such as grammar, general, intermediate or comprehensive school) are eligible. Exclusion Criteria: - Older or younger pupils or pupils from other school types or countries or schools who previously participated in an event where the Smokerface app was presented are not eligible. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Germany | University of Gießen | Giessen | Hessen |
Lead Sponsor | Collaborator |
---|---|
University of Giessen | German Center for Lung Research, Goethe University, Harvard University, Heidelberg University, Massachusetts General Hospital, Technische Universität München, The German Heart Foundation, Universität Duisburg-Essen, University Medical Center Goettingen, University of Bonn, University of Freiburg, University of Homburg |
Germany,
Brinker TJ, Seeger W. Photoaging Mobile Apps: A Novel Opportunity for Smoking Cessation? J Med Internet Res. 2015 Jul 27;17(7):e186. doi: 10.2196/jmir.4792. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The change in smoking prevalence between baseline and 24 months of follow-up between the two groups measured via questionnaires. | The change in smoking prevalence between baseline and 24 months of follow-up between the two groups. A smoker is defined as someone who claims to have smoked cigarettes at least once in the past 30 days. | 24 months post intervention | No |
Secondary | Difference in attitude towards smoking between the two groups at 24 months follow-up measured via questionnaires. | Difference in attitude towards smoking between the two groups at 24 months follow-up. | 24 months post intervention | No |
Secondary | The change in never-smokers between baseline and 24 months of follow-up between the two groups measured via questionnaires. | The change in never-smokers between baseline and 24 months of follow-up between the two groups measured via questionnaires. | 24 months post intervention | No |
Secondary | The difference in the number of quitters (=cigarette smokers at baseline but not at endline) between baseline and 24 months of follow-up between the two groups measured via questionnaires. | The difference in the number of quitters (=quitters are participants who are cigarette smokers at baseline but not at endline) between baseline and 24 months of follow-up between the two groups measured via questionnaires. | 24 months post intervention | No |
Secondary | The difference in the number of starters (=starters are participants who are not cigarette smokers at baseline but at endline) between baseline and 24 months of follow-up between the two groups measured via questionnaires. | The difference in the number of starters (=starters are participants who are not cigarette smokers at baseline but at endline) between baseline and 24 months of follow-up between the two groups measured via questionnaires. | 24 months post intervention | No |
Secondary | The change in smoking prevalence between baseline and 24 months of follow-up between female participants of the two groups measured via questionnaires. | 24 months post intervention | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00491335 -
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
|
N/A | |
Completed |
NCT02124200 -
High Cessation Rates in Smokers Using Personal Vaporizers
|
Phase 4 | |
Completed |
NCT01785147 -
Efficacy and Safety of BP1.4979 in Smoking Cessation
|
Phase 2 | |
Recruiting |
NCT01038414 -
Duration of Behavioral Counseling Treatment Needed to Optimize Smoking Abstinence
|
Phase 4 | |
Completed |
NCT02000921 -
Reduced Nicotine Content Cigarettes and Tobacco Switching Behaviors
|
N/A |